Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

Mughal TI, Yong A, Szydlo RM, Dazzi F, Olavarria E, Van RF, Kaeda J, Cross NC, Craddock C, Kanfer E, Apperley J, Goldman JM. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol. 2001; 115(3):569 - 574.


collapse authors with profiles